PDS Life Sciences' Ascentos Software, a Ready Preclinical Solution to Help in Cancer Treatment

By CIOReview | Wednesday, July 15, 2015
916
1569
289

ARLINGTON, N.J: Memorial Sloan Kettering Cancer Center, a private cancer center for better patient care has selected PDS Life Sciences’ Ascentos software. The software suite will manage and analyze data generated in its new GLP-compliant preclinical research laboratories. PDS Life Sciences is a provider of intuitive data management software and solutions for life sciences research.

Ascentos is a complete FDA SEND-ready preclinical solution because it captures data required by current and future versions of the CDISC SEND data standard. It includes toxicology, clinical pathology, reproductive toxicology and pathology modules that interface seamlessly to streamline data management from study setup to final reporting. The choice was basically based on its intuitive processes, rapid implementation and ability to automate fundamental laboratory workflows.

"We develop software that works like scientists think,” says Sayed Badrawi, CEO of PDS “As innovative companies and research institutions continue to choose PDS’ Ascentos over the alternatives, it’s become clear that building software for the user — not just the data being compiled — is a key driver of value in the market."